Completed
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
NCT00080236
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +13 more
- Locations
-
- Mayo Clinic Scottsdale Phoenix, Arizona, United States
- University of California Los Angeles Los Angeles, California, United States
- University of California San Francisco San Francisco, California, United States
- Indiana University Medical Center Indianapolis, Indiana, United States